Identity
- Security key
- 11935
- Ticker
- ASBP
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2025-02-20
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ASBP
Detail
Enriched 2026-08-14 20:47
- Market cap
- $9,235,018.42
- Shares outstanding (class)
- 1,295,234
- Shares outstanding (weighted)
- 1,295,234
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- —
- Location
- ESTERO, FL
- Homepage
- https://www.aspirebiolabs.com
- Description
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
Market cap and share counts drift.